New York, USA, November 2014, Veith Symposium: 41st Annual Symposium on Vascular and Endovascular Issue

Illness Severity Scoring Systems and Risk Prediction in Vascular Intensive Care Admissions

Treatment of Thoracoabdominal Aortic Aneurysms and Dissections with the Multilayer Flow Modulator: A Systematic Review

Contemporary Management of Critical Lower Limb Ischaemia in TASC D lesions with Subintimal Angioplasty in femoro-popliteal lesions , Tibial Angioplasty and Sequential compression biomechanical device for Infra-inguinal Arterial Occlusion. Experience and Quality of life outcome learned over 25 years.

Liege, Belgium, September 2014, IMAD 2014: 4th International Meeting on Aortic Diseases

Lessons Learned from Using the Multilayer fluid Modulator Outside of Indications for Use in 38 Cases.

Evaluation of the multilayer flow modulator in aneurysm repair using porcine animal models.

Changes in thread design of the multilayer flow modulator and the effects on biocompatibility.

Endothelization kinetics of multilayer versus single layer intra-arterial stents.

 

Guangzhou, China, July 2014, International Society of Vascular Surgery, Annual Congress

Illness Severity Scoring Systems and Risk Prediction in Vascular Intensive Care Admissions

Endothelialisation processes and kinetics of stents.

Nice, France, April 2014 , Congress of the ESCVS (European Society for Cardiovascular & Endovascular Surgery) 2014 

Illness severity scoring systems and risk prediction in vascular intensive care admissions: which score is best for contemporary practice?

Early mid-term results of the first 103 cases of multilayer flow modulator stent done under indication for use in the management of thoraco-abdominal aortic pathology from the independent global MFM registry

London UK, April 2014 , Charing Cross international symposium 2014

Illness severity scoring systems and risk prediction in vascular intensive care admissions: which score is best for contemporary practice?

Early mid-term results of the first 103 cases of multilayer flow modulator stent done under indication for use in the management of thoraco-abdominal aortic pathology from the independent global MFM registry

When Not to Implant the Multilayer Flow Modulator: Lessons Learned From Application Outside the Indications in Patients With Thoracoabdominal Pathologies

Milan, Italy, December 2014: 6th International Congress Aortic Surgery and Anesthesia "How to do it

How can the sac thrombosis (even if extensive but not complete) prevent rupture

New York, USA, November 2014, Veith Symposium: 41st Annual Symposium on Vascular and Endovascular Issues

DEBATE: Statins Have No Role To Play In Primary Prevention And Should Be Avoided In Most Patients

DEBATE: The MLFM Device Is A Disruptive Technology For Aortic Aneurysm And Dissection Based On The Results Of A Global Registry

The Phantom MLFM Aorto Bi-Iliac Device: A Fresh Perspective On The Treatment Of Aortic And Iliac Aneurysms

Antalya, Turkey, October 2014, Turkish Society of Cardiovascular Surgery, 13th Congress

Update on the Multilayer Flow Modulating Stent

Shanghai, China, October 2014, Endovascology 2014

When not to use the Multi-layer Flow Modulator: Lessons Learned from Using the Device Outside of Indications for Use in 38 Cases

Siena, Italy, September 2014, SiVEC: Siena Vascular & Endovascular Course 2014.

When not to use the multilayer flow modulator

Glasgow, Scotland, September 2014, CIRSE 2014.

When not to use the Multilayer Flow Modulator: lessons learned from using it outside indications for use in 38 cases

Guangzhou, China, July 2014, Interantional Society of Vascular Surgery, Annual Congress

Keynote Address: How to achieve success in vascular surgery: View from Ireland

Nice, France, April 2014 , Congress of the ESCVS (European Society for Cardiovascular & Endovascular Surgery) 2014 

Keynote Address: When not to use the multilayer flow modulator

Sao Paolo,  Brazil, April 2014, CICE 2014  

The New Bifurcated MFM for Thoracoabdominal Aortic Aneurysm. Does It Make a Difference?

Debate Open Surgery Is the Best Therapeutic Option for Short Neck AAA: Against the Motion: MFM Is the Best Option

When Not to Implant the MFM


Posters

Washington, USA, September 2014, TCT 2014: Transcatheter Cardiovascular Therapeutics

Lessons Learned From Application of the Multilayer Flow Modulator Device Outside the Indications in Patients With Thoracoabdominal Pathologies.

Assessment of Biocompatibility of the Multilayer Flow Modulator with Varying Thread Numbers.

Treatment of Rabbit Aneurysms with the Intracranial Multilayer Flow Modulator.

Treatment of Porcine Aneurysm Models with The Multilayer Flow Modulator

Endothelialization of the Multilayer Flow Modulator versus Single-Layer Arterial Stents.

Liege, Belgium, September 2014, IMAD 2014: 4th International Meeting on Aortic Diseases

Evaluation of the multilayer flow modulator in aneurysm repair using porcine animal models.

Changes in thread design of the multilayer flow modulator and the effects on biocompatibility.

Endothelization kinetics of multilayer versus single layer intra-arterial stents.